Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Clinical trial NCT05976763 · RECRUITING
Trial details
- NCT number
- NCT05976763
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-20
- Primary completion
- 2038-08-31
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.